Clinical Trial Update: Estrogen Hormone Protocol [Phase 3]

View source ↗

Summary

National Institute on Aging sponsored a Phase 3 trial of an estrogen hormone protocol for Alzheimer's disease. The trial status is Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Estrogen Hormone Protocol (estrogen)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED